tiprankstipranks
Fennec Pharmaceuticals (TSE:FRX)
NASDAQ:FRX
Canadian Market
FRX
Fennec Pharmaceuticals
RESEARCH TOOLSreports

Fennec Pharmaceuticals (FRX) Income Statement

36 Followers

Fennec Pharmaceuticals Income Statement

Last quarter (Q4 2025), Fennec Pharmaceuticals's total revenue was $13.99M, an increase of 76.51% from the same quarter last year. In Q4, Fennec Pharmaceuticals's net income was $-5.22M. See Fennec Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 45.42M$ 47.54M$ 21.25M$ 1.53M$ 0.00
Gross Profit
$ 41.59M$ 44.35M$ 19.99M$ 1.45M$ 0.00
Operating Expenses
$ 48.46M$ 41.79M$ 32.76M$ 24.04M$ 17.22M
Depreciation and Amortization
$ 0.00$ 800.00K$ 287.00K$ 149.00K$ 17.22M
EBITDA
$ -6.86M$ 4.80M$ -12.65M$ -22.74M$ -17.18M
Operating Income
$ -6.86M$ 2.57M$ -12.77M$ -22.59M$ -17.22M
Other Income/Expenses
$ -3.41M$ -2.64M$ -3.27M$ -1.13M$ -123.00K
Pretax Income
$ -10.27M$ -71.00K$ -16.05M$ -23.71M$ -17.35M
Net Income
$ -10.27M$ -436.00K$ -16.05M$ -23.86M$ -17.46M
Per Share Metrics
Basic EPS
$ -0.36$ -0.02$ -0.60$ -0.91$ -0.67
Diluted EPS
$ -0.36$ -0.02$ -0.60$ -0.91$ -0.67
Weighted Average Shares Outstanding
 28.58M 21.80M 26.57M 26.27M 25.89M
Weighted Average Shares Outstanding (Diluted)
 28.58M 27.30M 26.57M 26.27M 26.01M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History